🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To evaluate safety, tolerance and efficacy of TASO(TGF-β2 targeting anti-se...
Status
Completed
Location
Seoul National University Hospital
Start Date
2021-03-09
Trial ID
NCT04862767
Treatments Being Tested
This is a longitudinal, multiple-center, observational study of patients ge...
Status
Unknown
Location
Department of Neurology, Peking Union Medical College Hospital
Start Date
2022-01-01
Trial ID
NCT05187260
Treatments Being Tested
The primary objectives of this study are to assess: (1) whether the combina...
Status
Recruiting
Location
UCLA Medical Center
Start Date
2016-05
Trial ID
NCT02781883
Treatments Being Tested
This is a Phase 1, open-label, non-randomized, dose-escalation study to det...
Status
Completed
Location
Duke University Medical Center
Start Date
2007-03
Trial ID
NCT00466583
Treatments Being Tested
This is a phase 1, multi-center, double-blind, placebo-controlled, multiple...
Status
Completed
Location
University of California San Diego
Start Date
2021-02-16
Trial ID
NCT04539041
Treatments Being Tested
This study is being conducted to evaluate individualised antisense oligonuc...
Status
Active Not Recruiting
Location
Great Ormond Street Hospital
Start Date
2026-01-13
Trial ID
NCT07410143
Treatments Being Tested
This research project entails delivery of a personalized antisense oligonuc...
Status
Active Not Recruiting
Location
Columbia University
Start Date
2024-02-21
Trial ID
NCT06706388
Treatments Being Tested
The purpose is to assess the Safety, Tolerability, Pharmacokinetics, and Ph...
Status
Completed
Location
Ionis Investigative Site
Start Date
2017-08-28
Trial ID
NCT03263507
Treatments Being Tested
This open-label extension study aims to evaluate the long-term safety and t...
Status
Enrolling By Invitation
Location
Fondazione Serena ETS - Centro Clinico NeMO Milano
Start Date
2026-04-20
Trial ID
NCT07573631
Treatments Being Tested
WVE-HDSNP2-002 is an open-label extension (OLE) study to evaluate the safet...
Status
Terminated
Location
Westmead Hospital
Start Date
2019-09-24
Trial ID
NCT04617860
Treatments Being Tested